Table 4.

Effects of MMDA on hematological traits at d 42 on trial (d 273 of age).

Treatment groups		T1	T2	T3	T4	T4	T6	T7
Hens	no	10	10	10	10	10	10	10
Replicates	no	10	10	10	10	10	10	10
MMDA	g/kg		2		1		2	3	ANOVA
AFB1	mg/kg			0.05	0.05	0.50	0.50	0.50
T2-toxin	mg/kg			1.5	1.5	2.0	2.0	2.0
		Body weight
Body weight	g
		Hematological traits
Erythrocytes	T/L	2.29 ± 0.04ab	2.13 ± 0.12a	2.30 ± 0.08ab	2.19 ± 0.12ab	2.28 ± 0.04ab	2.32 ± 0.14b	2.23 ± 0.16ab	0.021
Leukocytes	G/L	7.71 ± 1.89	7.94 ± 1.76	8.77 ± 5.66	8.97 ± 1.23	7.01 ± 1.03	6.89 ± 1.45	7.14 ± 1.56	0.610
Lymphocytes	%	42.0 ± 6.6	44.9 ± 6.4	44.1 ± 7.7	47.0 ± 6.1	37.6 ± 6.7	36.6 ± 6.6	39.0 ± 8.5	0.172
Heterophils	%	55.3 ± 6.8	51.4 ± 6.6	51.3 ± 10.2	49.6 ± 5.9	58.2 ± 6.9	58.7 ± 6.4	56.7 ± 8.5	0.122
Monocytes	%	1.4 ± 0.8	2.6 ± 1.1	3.1 ± 2.6	1.7 ± 1.1	1.6 ± 1.5	1.7 ± 1.1	1.9 ± 0.4	0.253
Eosinophils	%	0 ± 0	0 ± 0	0 ± 0	0.4 ± 0.8	0.8 ± 1.1	0.9 ± 1.2	0.6 ± 0.8	0.119
Basophils	%	1.3 ± 0.8	1.1 ± 1.1	1.4 ± 1.1	1.7 ± 1.1	1.8 ± 1.1	2.1 ± 1.3	1.9 ± 1.2	0.659
Hemoglobin	g/L	72.14 ± 3.44a	74.43 ± 3.64a	83.14 ± 7.84bc	73.57 ± 10.72ab	85.00 ± 1.91c	86.14 ± 4.49c	84.86 ± 4.38c	<0.001
Hematocrit	L/L	0.23 ± 0.01b	0.21 ± 0.01a	0.22 ± 0.01ab	0.22 ± 0.01ab	0.22 ± 0.01ab	0.22 ± 0.01ab	0.21 ± 0.02ab	0.025
MCV1	Fl	99.41 ± 2.31c	96.54 ± 1.15abc	94.47 ± 2.09ab	97.66 ± 2.22bc	94.63 ± 2.42ab	93.70 ± 2.10a	94.17 ± 2.77ab	<0.001
MCH2	Pg	31.43 ± 0.33abc	31.32 ± 0.26ab	38.39 ± 2.92bcd	34.01 ± 4.03a	39.37 ± 0.77cd	39.66 ± 1.06cd	40.49 ± 1.42d	<0.001
MCHC3	g/dl	31.61 ± 0.32a	31.33 ± 0.52a	36.29 ± 3.07b	29.21 ± 9.36a	37.24 ± 0.62b	39.66 ± 1.06b	40.49 ± 1.42b	<0.001

Abbreviations: AFB1, aflatoxin B1; MCH, mean corpuscular hemoglobin, MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; MMDA, multicomponent mycotoxin detoxifying agent.

Different superscripts in same row are significant (a/b: P ≤ 0.05).

¹Mean corpuscular volume;

²Mean corpuscular hemoglobin;

³Mean corpuscular hemoglobin concentration.